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Long-term survival after vascular surgery: Specific
influence of cardiac factors and implications for
preoperative evaluation
Martin R. Back, MD,a Fabian Leo,a David Cuthbertson, MS,b Brad L. Johnson, MD,a
Murray L. Shames, MD,a and Dennis F. Bandyk, MD,a Tampa, Fla
Objective: We sought to identify specific determinants of long-term cardiac events and survival in patients undergoing
major arterial operations after preoperative cardiac risk stratification by American College of Cardiology/American
Heart Association guidelines. A secondary goal was to define the potential long-term protective effect of previous
coronary revascularization (coronary artery bypass grafting [CABG] or percutaneous coronary intervention [PCI]) in
patients with vascular disease.
Methods: Four hundred fifty-nine patients underwent risk stratification (high, intermediate, low) before 534 consecutive
elective or urgent (<24 hours after presentation) open cerebrovascular, aortic, or lower limb reconstruction procedures
between August 1996 and January 2000. Long-term follow-up (mean, 56 14 months) was possible in 97% of patients.
The Kaplan-Meier method was used for survival data. Long-term prognostic variables were identified with the
multivariate Cox proportional hazards model and contingency table analysis censoring early (<30 days) perioperative
deaths.
Results: While 5-year survival was 72% for the overall cohort, cardiac causes accounted for only 24% of all deaths, and new
cardiac events (myocardial infarction, congestive heart failure, arrhythmia, unstable angina, new coronary angiography,
new CABG or PCI, cardiac death) affected only 4.6% of patients per year during follow-up. High cardiac risk
stratification level (hazards ratio [HR], 2.2, 95% confidence interval [CI], 1.4-3.4), adverse perioperative cardiac events
(myocardial infarction, congestive heart failure, ventricular arrhythmia; HR, 2.2; 95% CI, 1.2-4.1), and age (HR, 0.33;
95% CI, 0.2-0.6) were independently prognostic for late mortality. Preoperative cardiac risk levels also correlated with
new cardiac event rates (P < .01) and late cardiac mortality (P  .02). Modestly improved survival in patients who had
undergone CABG or PCI less than 5 years before vascular operations compared with those who had undergone
revascularization 5 or more years previously and those at high risk without previous coronary intervention (73% vs 58%
vs 62% 5-year survival; P  .02) could be demonstrated with univariate testing, but not with multivariate analysis. Type
of operation, urgency, noncardiac complications, and presence of diabetes did not affect long-term survival.
Conclusion: Despite cardiac events being a less common cause of late mortality after vascular surgery, perioperative cardiac
factors (age, preoperative risk level, early cardiac complications) are the primary determinants of patient longevity.
Patients undergoing more recent (<5 years) CABG or PCI before vascular surgery do not have an obvious survival
advantage compared with patients at high cardiac risk without previous coronary interventions. ( J Vasc Surg 2004;40:
752-60.)Shorter long-term survival observed after vascular op-
erations, such as elective open abdominal aortic aneurysm
(AAA) repair, compared with age-matched and sex-
matched control populations,1,2 have generally been attrib-
uted to a high relative incidence of coronary artery disease
(CAD) in patients with vascular disease and late death from
cardiac causes. Numerous series have shown that cardiac
causes account on average for 40% of late deaths, and
outnumber all other causes of late mortality after AAA
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doi:10.1016/j.jvs.2004.07.038752repair1-4 or other major arterial reconstruction.5 Previous
coronary revascularization (coronary artery bypass grafting
[CABG], percutaneous coronary intervention [PCI; angio-
plasty or stenting]) performed within 5 years of major
noncardiac surgery (thoracic, abdominal, head and neck)6,7
or vascular surgery6-9 is believed to reduce perioperative
mortality and early adverse cardiac events. However, a
potential long-term protective effect of coronary revascu-
larization before vascular surgery has not been addressed in
a prospective trial. Relative to the 90% 5-year survival rate in
patients undergoing CABG or PCI to treat isolated coro-
nary disease, presence of peripheral arterial disease (carotid,
aortic, lower limb) despite treatment of CAD in the Bypass
Angioplasty Revascularization Investigation was associated
with only 76% survival at 5 years.10 These results suggest
that shorter longevity may be unavoidable in the presence
of systemic atherosclerosis, despite coronary intervention.
Indeed, Hertzer et al9 were only able to show a long-term
survival benefit in patients undergoing coronary bypass
operations before elective open AAA repair (75% at 5
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inoperable CAD (29% at 5 yrs) but not patients with
untreated multiple-vessel compensated CAD (71% at 5
years).
The current study is a long-term corollary to recent
investigations,8,11 and demonstrates the early prognostic
value of preoperative cardiac risk stratification using Amer-
ican College of Cardiology/American Heart Association
(ACC/AHA) guidelines12 before major peripheral arterial
reconstruction. Our primary goal was to identify specific
determinants of late cardiac events and death after vascular
surgery. As a secondary analysis, late outcomes were com-
pared between patients who had or had not undergone
CABG or PCI before peripheral vascular operations.
METHODS
Study population. ACC/AHA guidelines for preop-
erative cardiac risk evaluation before noncardiac surgery
were implemented as a clinical pathway in August 1996 at
the James A. Haley Veterans Hospital in Tampa, Fla. All
459 patients undergoing 534 consecutive nonemergent
major open arterial reconstructions between August 1996
and January 2000 were preoperatively evaluated with the
cardiac pathway, and were included in the study. The group
comprised 454 men and 5 women, with mean age 66 10
years (range, 44-89 years). Only patients with ruptured
aortoiliac aneurysms, ongoing hemorrhage, or preopera-
tive hypotension were excluded from the series. Details of
the risk stratification algorithm have been described.8,11,12
Risk estimation was prospectively determined by cardiol-
ogy, anesthesia, or vascular staff before elective (n  481)
and urgent (within 24 hours of presentation; n  53)
operations, but additional preoperative cardiac testing,
even if indicated, was not possible before urgent vascular
procedures. The need for preoperative cardiac stress testing
or coronary angiography was determined on the basis of
major, intermediate, or minor clinical risk factors predictive
of adverse perioperative cardiac events,12 but with final
decision for testing made on the cardiologists’ prerogative.
Previous CABG (n  101) or PCI (n  28) had been
performed in 27% of patients undergoing elective arterial
reconstructions. Patients remaining symptom-free within 5
years after previous coronary revascularization were gener-
Table I. Preexisting cardiac variables and results of additio
risk based on ACC/AHA algorithm guidelines
Components of risk algorithm Low
No. of Eagle criteria* 0-1
LV ejection fraction (%) 50
Cardiac stress imaging Normal
Coronary angiography (v)
(No. of vessels with CAD)
0-1
ACC/AHA, American College of Cardiology/American Hospital Associati
artery disease.
*Age older than 70 years, diabetes mellitus, angina, history of myocardial inally assumed to be at low cardiac risk, whereas additional
testing was warranted if there were recurrent ischemic
symptoms, or CABG or PCI had been performed more
than 5 years previously.12 On the basis of cardiac test
results, only 13 patients (3%) in the entire series, and none
with previous CABG or PCI, underwent coronary revascu-
larization immediately before (within 2 months) vascular
operations. Final preoperative cardiac risk was prospectively
stratified from clinical parameters (modified Eagle crite-
ria13), the results of cardiac testing, and selective revascu-
larization, as reported previously8,11 (Table I). Risk was
assigned as the highest level category for which the patient
demonstrated at least 1 of the criteria.
Specific types of open vascular procedures performed
were cerebrovascular (eg, carotid endarterectomy) in 151
patients (28%), aortic (graft repair of aneurysms or occlu-
sive disease) in 135 patients (25%), extra-anatomic inflow
(axillofemoral or cross-femoral bypass) in 53 patients
(10%), and infrainguinal (autologous vein or prosthetic
bypass) in 195 patients (37%). Perioperative management
has been detailed,8,11 and included attempted routine use
of aspirin and -blockers after pathway implementation.
Patients received perioperative (up to 1 month) orally or
intravenously administered metoprolol, titrating to a heart
rate less than 80 to 90 bpm, unless the heart rate was less
than 55 bpm or there was heart block or hypotension
(systolic pressure 100 mm Hg). Ninety-three percent of
study patients (427 of 459) received -blockers. Serial
electrocardiograms (ECGs) were performed and cardiac
enzyme levels determined only in patients with episodes of
chest pain, pulmonary compromise, dysrhythmias, or hy-
potension potentially due to cardiac ischemia. Adverse peri-
operative events were defined within 30 days of vascular
surgery, and included fatal and nonfatal cardiac events: (1)
acute myocardial infarction (MI) demonstrated on ECGs
(new Q-wave); creatine kinase myocardial bound, greater
than 5% of elevated creatine kinase; or echocardiography
(new wall motion abnormality); (2) unstable angina; (3)
congestive heart failure (CHF) accompanied by cardiac
ischemia (ECG changes) or new wall motion abnormality;
or (4) sustained ventricular dysrhythmia requiring infusion
of antiarrhythmic agents). Other adverse perioperative
esting used to estimate and stratify preoperative cardiac
Risk categories
Intermediate High
2 3
50 35  CHF
Fixed defect Reversible defect
1-2 2-3
k Force; LV, left ventricular; CHF, congestive heart failure; CAD, coronary
on, congestive heart failure, or ventricular arrhythmias.nal t
on Tas
farcti
rder,
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for unplanned repeat operation, and death.
Long-term outcomes were determined with retrospec-
tive review of the regional and national components of the
Veterans Affairs (VA) computerized patient records system,
confirmation of deaths using the Social Security Death
Index (available at:www.rootsweb.com), and phone con-
tact with surviving relatives only when cause of death could
not be ascertained (8 of 120; 7%). Long-term evaluation
was possible in 97% of patients, with a mean follow-up of 56
 14 months after vascular operations. Recording was
made of admissions at VA or civilian hospitals for manage-
ment of MI, unstable angina, CHF, or arrhythmias; perfor-
mance of diagnostic coronary angiography; new CABG or
PCI, and death. Individual late outcomes included a new
nonfatal MI, new CABG or PCI, cardiac death, or all-cause
mortality. A composite outcome measure, “new cardiac
event,” encompassed any new cardiac event (MI, unstable
angina, CHF, arrhythmia, death) or coronary intervention
(angiography, PCI, CABG) occurring during follow-up.
Statistical analysis. Late outcomes were compared
between various patient subgroups to identify potential
prognostic factors. The long-term influence of patient age,
presence of diabetes mellitus, previous coronary revascular-
ization status, final preoperative cardiac risk stratification
level (low, intermediate, high), urgency of vascular opera-
tion, type and location of arterial reconstruction, and ad-
verse perioperative cardiac events, major noncardiac com-
plications, or unplanned repeat operations were analyzed.
Age was considered both as a continuous variable and with
patients divided into quartiles of overall age distribution.
Coronary revascularization subgroups included remote
(CABG or PCI5 years before vascular operation) or more
recent (CABG or PCI within 5 years) interventions, and
were compared with outcomes in patients at high, interme-
diate, and low risk without previous revascularization. The
incidence of late events was compared between patient
subgroups with 2 analysis. Multiple occurrences of a spe-
cific late event (eg, recurrent MI, repeat coronary angiog-
raphy) during follow-up were counted as a single outcome
in individual patients. Long-term survival was estimated
Table II. Causes of late deaths in series
Primary cause of late death No. of p
Cardiac 2
Neoplasm 2
Stroke 1
Pulmonary 1
Sepsis or multiple organ failure 1
Perioperative death after subsequent
operation (noncardiac causes)
Renal failure
Other causes* 1
Unknown
Total 12
Overall cohort includes patients surviving initial vascular operations and wit
*Trauma or accident, cirrhosis or liver disease, degenerative neurologic disowith Kaplan-Meier life table methods, with patient sub-
group data compared with log-rank testing. Potential sur-
vival correlates were further scrutinized with univariate and
multivariate Cox proportional hazards models, with calcu-
lated risk ratio (hazard ratio [HR] for independent vari-
ables reported with 95% confidence interval (CI). Early
(perioperative) deaths were censored to optimize identifi-
cation of the potential long-term influence of perioperative
factors on survival, although no differences in results were
found when multivariate analyses were done with and with-
out early mortality censoring. For patients with multiple
arterial reconstructions, survival was considered from the
earliest procedure done within the study interval. Data are
reported as mean  SD, where appropriate. The study was
approved by our university institutional review board.
RESULTS
Early (perioperative) outcomes. Perioperative
deaths (9.4% vs 1.7%; P .005) and cardiac deaths (7.6% vs
0.4%; P  .001) were more frequent after urgent than
elective arterial reconstructions. Adverse cardiac events
were more common after urgent operations, but not to a
significant degree (9.4% vs 4.8%; P  .18), with MI ac-
counting for most of the cardiac complications in both
groups. Differences in early outcomes between patient
subgroups undergoing elective reconstructions included
significantly more fatal cardiac events (P  .02) and non-
fatal cardiac events (P  .04), but not all-cause deaths, in
patients at high preoperative risk.11
Late outcomes. Late deaths occurred in 120 of 430
patients (28%) who initially survived arterial reconstruc-
tions. Causes of late death could be determined in 95% of
patients (Table II). Cardiac causes (MI, CHF, arrhythmia)
rivaled advanced neoplasms as the leading contributor to
death, but overall accounted for only one fourth of late
deaths in the series. All early deaths after subsequent surgi-
cal procedures listed in Table II were not due to cardiac
causes. Late deaths due to sepsis or multiple organ failure
were related to overwhelming infection or gastrointestinal
catastrophe without evidence of significant cardiac events.
Dialysis had been stopped or was not instituted in patients
ts Series (%) Deaths (%)
6.7 24
6.7 24
3.5 13
2.6 10
2.3 8
1.4 5
0.9 3
2.3 8
1.4 5
27.8 100
wn follow-up (N  430).
pulmonary embolism.atien
9
9
5
1
0
6
4
0
6
0
h kno
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also relatively infrequent during follow-up. The number
and average annual incidence of new MI (25; 1.4% of
patients per year), new CABG or PCI (22; 1.2% of patients
per year), and cardiac deaths (24; 1.3% of patients per year)
in patients after elective vascular operations were similar. A
“new cardiac event” during follow-up (MI, unstable an-
gina, CHF, arrhythmia, coronary angiography, new CABG
or PCI, cardiac death) affected 21% of patients (83 of 396)
after elective operations, for an average annual incidence of
cardiac events (4.6% of patients per year) that was less than
the annual all-cause death rate (6.0% of patients per year).
With life table analysis with inclusion of early deaths, the
overall 5-year survival rate after elective or urgent arterial
reconstruction was 72%.
Late outcome correlates. Univariate determinants of
long-term survival were identified by patient subgroup
comparisons from life table analysis. Patient age (P .001;
Fig 1), preoperative cardiac risk level (P  .001; Fig 2),
previous coronary revascularization status (P .02; Fig 3),
and presence of adverse cardiac events after vascular oper-
ations (P  .002; Fig 4) significantly influenced long-term
survival after censoring early deaths. Specific univariate
correlates of improved longevity included younger age
quartiles (ages 44-60 years and 61-65 years), whereas high
preoperative cardiac risk, high risk without previous coro-
nary revascularization, remote (5 years) previous CABG
or PCI, and nonfatal perioperative cardiac events were
Fig 1. Significant differences in 5-year survival after vasc
patients. SE, Standard error for Kaplan-Meier estimates.associated with shorter survival at Cox proportional hazards
modeling. Multivariate analysis revealed age range 44 to 60
years (HR, 0.33; 95% CI, 0.19-0.58), age range 61 to 65
years (HR, 0.64; 95% CI, 0.42-1.0), high preoperative
cardiac risk (HR, 2.17; 95% CI, 1.4-3.4), and nonfatal
perioperative cardiac events (HR, 2.17; 95% CI, 1.2-4.1) to
be independently prognostic of long-term survival. Periop-
erative factors that did not influence late survival included
diabetes mellitus, type of arterial reconstruction, urgency of
operation, and occurrence of major perioperative noncar-
diac complications or unplanned repeat operations.
Further evaluation of the prognostic value of preoper-
ative risk stratification on late cardiac outcomes revealed a
greater incidence of cardiac events during follow-up not
only in patients at high risk but also in those at intermediate
risk (Table III). Indeed, new nonfatal or fatal cardiac events
and late cardiac deaths were more frequent in patients at
intermediate risk than in patients at high risk, which sug-
gests progression of coronary disease and symptoms in
some patients at intermediate risk. The potential protective
effect of previous coronary revascularization on late cardiac
events was further evaluated with univariate analysis (Table
IV). The incidence of new MI (P  .6) or new CABG or
PCI (P  .11) did not significantly differ between patients
having remote (5 years) previous CABG or PCI, more
recent (5 years) coronary interventions, or no previous
revascularization and high or intermediate or low levels of
perioperative cardiac risk. Despite a low incidence of repeat
perations between age quartile groups favoring youngerular o
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tion, new cardiac events or interventions (P  .01) and
cardiac deaths (P  .01) were significantly more common
in patients after previous CABG or PCI compared with
patients with no revascularization. However, more recent
CABG or PCI was associated with reduced late death (P
.02, Table IV) at univariate comparison with patients with
remote revascularization and patients at high risk without
previous coronary interventions, and thus mirrored the life
table results between these groups (Fig 3). However, sur-
vival benefit in patients with more recent CABG or PCI
could not be demonstrated with multivariate analysis.
DISCUSSION
The intent of the ACC/AHA guidelines12 is to provide
a standardized method of evaluating cardiac risk before
noncardiac surgery and selecting patients at risk for more
extensive testing (eg, stress imaging, coronary angiogra-
phy). Several recent reports have described implementation
of ACC/AHA guidelines, and have associated risk stratifi-
cation with low overall perioperative mortality.14-17 How-
ever, only 1 of these studies evaluated algorithm utility
relative to a comparable historic cohort in which patients
nearly uniformly underwent preoperative stress testing be-
fore elective aortic surgery.17 No differences were found in
the rates of perioperative death or myocardial infarction
after ACC/AHA algorithm implementation, and cost sav-
ings were realized as a result of reduced preoperative re-
Fig 2. Significant differences in 5-year survival betwee
favoring low risk patients. SE, Standard error.source use (ie, less stress testing, cardiac catheterization,
and coronary revascularization).17 The current study de-
scribing long-term outcomes and our corollary precur-
sors8,11 is the largest prospective series to date to examine
preoperative use of the ACC/AHA algorithm before
higher risk arterial reconstruction. Reflecting the results of
Froehlich et al,17 stress testing was limited to 46% of our
patients, and only 37% of patients with minor or no cardiac
risk factors on the basis of ACC/AHA guidelines.11 Also
similar to the findings of Froehlich et al,17 relatively few
patients (3%) received preoperative coronary revasculariza-
tion, despite 18% of our overall group undergoing diagnos-
tic cardiac catheterization.11
Early adverse cardiac events were predicted by preop-
erative high-risk stratification level or presence of 3-vessel
CAD, but not by results of stress imaging.11 Others have
shown the low predictive value of reversible wall defects or
radionuclide redistribution found during preoperative car-
diac stress imaging.18,19 We recommend a limited role for
stress testing, with the presence of multiple risk factors (3
Eagle criteria or significant active ischemic symptoms) used
instead to determine the need for coronary angiography.
Numerous studies have described long-term survival
after repair of AAA1-4,9,20,21 and other peripheral arterial
reconstructions5,22-25 (Table V). Five-year survival in these
patients ranges from 50% to 75%, and averaged approxi-
mately 70% in more recent series. Cardiac causes account
for roughly 40% of late deaths in most series, and outnum-
operatively determined cardiac risk stratification levelsn pre
dicate
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The annual rate of cardiac death seen in several AAA series
(1.8%-2.9% of patients per year)1,4,20 is in contrast to the
lower value in our patients after arterial reconstruction
(1.3% of patients per year). Indeed, the equal contributions
of cardiac events and cancer to late death and the low
annual cardiac death rate found in our series resemble data
for the age-matched and sex-matched control population,
but not patients with AAA, followed up in the prospective
Canadian aneurysm study.1 The long-term studies of
Hertzer et al9,21 are also comparable with ours, inasmuch as
the annual cardiac death rate was 1.5% in a group in which
28% of patients underwent CABG before AAA repair.9
Several potential factors may explain these disparities. Ob-
vious differences in survival after various types of vascular
operations (AAA vs peripheral vascular disease) do not
appear to exist when comparing different series, and subtle
differences found by L’Italien et al23 were explained by
varying degrees of preexisting CAD within surgical groups.
Second, the limited availability of complete follow-up data
(60%-80% in most series) may contribute to variability in
reporting survival and causes of death. Aided by patient
tracking within the computerized VA database, determina-
tion of cause of death and long-term follow-up was possible
in greater than 95% of our series, and rivals the complete-
ness of the prospective Canadian study.1 Last, annual rates
Fig 3. Significant differences in 5-year survival with
previous coronary revascularization (R 5 years and R
(NR) estimated to be at low, intermediate, or high risk,
error (SE) less than 10% for each group except where inof both nonfatal (3.3%) and fatal (1.3%) late cardiac events
were relatively low in the current series, and only a small
fraction (1.2% of patients per year) required late coronary
revascularization. Combined nonfatal and fatal late cardiac
events (4.6% per year) were surprisingly less frequent than
annual all-cause deaths (6% per year). These results parallel
national trends in CAD morbidity and mortality,26 and we
speculate that long-term risk modification and pharmaco-
logic management (-blockers, antiplatelet agents, statin
drugs) initiated during preoperative cardiac evaluation may
potentially alter the natural history of CAD or at least its
clinical manifestations. In other AAA and peripheral vascu-
lar disease series, and clearly within VA studies such as ours,
survival trends are reported for male-dominated cohorts,
and any extrapolation of results to female populations
remains speculative until potential gender differences can
be further addressed.
Various prognostic factors have been associated with
long-term survival after vascular surgery (Table V). As
expected, more advanced age at operation correlated with
shortened survival in several studies,1,2,4,20,21,25 and paral-
lels our findings. Although ill-defined in some studies,
preexisting cardiac disease or symptoms identified preoper-
atively were predictive of shorter survival in many re-
ports.1,2,4,9,20,21,25 Stratified levels of cardiac risk estimated
preoperatively with ACC/AHA guidelines correlated with
ariate) log-rank testing between patients undergoing
ears), patients without previous coronary interventions
atients undergoing urgent vascular operations. Standard
d.(univ
5 y
and p
tions.
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as well as predicted long-term survival, in our experience.
Yeager et al22 studied the long-term effects of early adverse
cardiac events after vascular operations. Only hemodynam-
ically or clinically apparent perioperative MI, not “silent” or
“chemical” MI (ECG changes or creatine kinase, myocar-
dial bound, elevation only) had a negative effect on late
survival in that series. However, elevated troponin I levels
are associated with higher 1-year mortality in the recent
cardiology literature,27 and may suggest a prognostic role
for troponin-detected, “silent” ischemia.
Fig 4. Significantly reduced 5-year survival in patient
congestive heart failure, ventricular arrhythmias) after vas
Standard error less than 10% in group without complica
Table III. Differences in long-term incidence of fatal and
groups
Event
Low (n  291)
n % n
Nonfatal MI 14 4.8 6
New CABG/PCI 13 4.5 4
New cardiac event 45 15 23
Late cardiac death 12 4.1 8
Overall cohort includes patients surviving elective vascular operations with
MI, Myocardial infarction; CABG/PCI, coronary artery bypass grafting or p
*Significant difference between risk groups.A potential limitation of our study was the absence of
routine cardiac enzyme measurements postoperatively,
which may have led to underestimation of the overall
incidence of ischemic cardiac events. However, clinically
evident cardiac events (MI, CHF, ventricular arrhythmia),
but not early noncardiac complications or unplanned re-
peat operation, did have a negative influence on long-term
survival after arterial reconstruction, in our experience. Of
potential noncardiac factors investigated, only the presence
of chronic renal insufficiency and cerebrovascular disease
were associated with reduced survival in multiple stud-
h early adverse cardiac events (myocardial infarction,
operations, even with censoring of perioperative deaths.
fatal cardiac events between cardiac risk stratification
k category
P
rmediate
 58) High (n  47)
% n %
10.3 5 10.6 .19
6.9 4 8.5 .40
40 15 32 .01*
13.8 4 8.5 .02*
follow-up (N  396).
aneous coronary intervention.s wit
cularnon
Ris
Inte
(n
known
ercut
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present study.
Coronary revascularization performed in the previ-
ous 5 years provides short-term (perioperative) protec-
tion from adverse cardiac events and death after major
noncardiac surgery6,7 and elective vascular surgery,6-9
with roughly equal protection afforded by CABG or
PCI.7,8 However, there is limited description of any
long-term protection provided by coronary revascular-
ization before vascular surgery, and a secondary retro-
spective analysis within our study was performed to
address the issue of previous CABG or PCI and late
events. Coronary interventions performed within 5 years
before vascular operations conferred at best a modest
survival advantage over revascularization performed 5 or
Table IV. Differences in long-term incidence of fatal and
with remote coronary revascularization (5 years before v
previous intervention with high, intermediate, or low card
Event
Revascularization
5 Years
(n  39)
5 Yea
(n  72
n % n
Nonfatal MI 4 10.3 5
New CABG/PCI 4 10.3 1
New cardiac event 14 36 21
Late cardiac death 8 20.5 5
Late death 16 41 20
Overall cohort includes patients surviving elective vascular operations with
CABG, Coronary artery bypass grafting; PCI, percutaneous coronary interv
*Significant difference between groups.
Table V. Recent studies reporting long-term survival* aft
cardiac causes to late death, and factors predictive for late m
Author (Year) Cohort No.
5-Year
survival (%)
Cardia
deaths (%
Hollier4 (1984) AAA 1087 68 38
Hertzer9 (1987) AAA 246 72 24
Roger2 (1989) AAA 131 63 41
Johnston1 (1994) AAA 680 68 44
Yeager22 (1994) PVD 93 60 at 4 y —
L’Italien23 (1995) PVD 547 74-90 at 4 y
Massie24 (1997) PVD 140 70 at 4 y 55
Koskas20 (1997) AAA 794 67 —
McFalls5 (1998) PVD 115 61 at 4 y 40
Kazmers25 (2002) PVD 310 55-61 —
Hertzer21 (2002) AAA 1135 75 23
AAA, Abdominal aortic aneurysm series; PVD, major arterial reconstruct
percutaneous coronary intervention; CRI, chronic renal insufficiency; COPD
*Actuarial and life table estimates.
†Univariate or multivariate analysis.
‡Event such as myocardial infarction.more years previously or in patients at high risk, by
univariate analysis but not by multivariate analysis with-
out prior revascularization. Relative to the independent
predictors of longevity (age, preoperative cardiac risk
level, early cardiac complication), coronary revascular-
ization status therefore had no obvious influence on late
survival. A controlled prospective trial is needed to de-
termine whether there are any late protective effects of
CABG or PCI performed before vascular surgery, and
which patient groups may benefit.
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